British Columbia Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$115M Sell
124,982
-25,525
-17% -$25.9M 0.68% 24
2025
Q4
$162M Buy
150,507
+16,085
+12% +$15.4M 0.85% 17
2025
Q3
$103M Sell
134,422
-10,962
-8% -$8.16M 0.59% 30
2025
Q2
$113M Sell
145,384
-27,369
-16% -$21.3M 0.66% 25
2025
Q1
$143M Buy
172,753
+1,063
+0.6% +$885K 0.88% 18
2024
Q4
$133M Buy
171,690
+30,055
+21% +$24.9M 0.79% 18
2024
Q3
$125M Sell
141,635
-25,332
-15% -$22.8M 0.75% 25
2024
Q2
$151M Buy
166,967
+56,234
+51% +$45M 0.91% 20
2024
Q1
$86.1M Buy
110,733
+17,847
+19% +$12.7M 0.6% 34
2023
Q4
$54.1M Buy
92,886
+19,478
+27% +$11.4M 0.44% 49
2023
Q3
$39.4M Buy
73,408
+342
+0.5% +$176K 0.37% 65
2023
Q2
$34.3M Buy
73,066
+847
+1% +$355K 0.32% 72
2023
Q1
$24.8M Buy
72,219
+547
+0.8% +$184K 0.26% 73
2022
Q4
$26.2M Sell
71,672
-8,361
-10% -$2.96M 0.29% 70
2022
Q3
$25.9M Sell
80,033
-14,012
-15% -$4.44M 0.29% 68
2022
Q2
$30.5M Sell
94,045
-31,681
-25% -$9.51M 0.29% 70
2022
Q1
$36M Sell
125,726
-17,228
-12% -$4.43M 0.23% 79
2021
Q4
$39.5M Sell
142,954
-7,791
-5% -$1.98M 0.22% 84
2021
Q3
$34.8M Sell
150,745
-151
-0.1% -$37.3K 0.21% 91
2021
Q2
$34.6M Buy
150,896
+9,531
+7% +$1.91M 0.21% 89
2021
Q1
$26.4M Sell
141,365
-4,313
-3% -$844K 0.19% 93
2020
Q4
$24.6M Sell
145,678
-3,840
-3% -$573K 0.17% 110
2020
Q3
$22.1M Buy
149,518
+11,476
+8% +$1.78M 0.18% 108
2020
Q2
$22.7M Buy
138,042
+43,434
+46% +$6.67M 0.23% 95
2020
Q1
$13.1M Sell
94,608
-110,427
-54% -$15.2M 0.22% 90
2019
Q4
$26.9M Sell
205,035
-12,774
-6% -$1.48M 0.2% 113
2019
Q3
$24.4M Sell
217,809
-42,141
-16% -$4.69M 0.24% 96
2019
Q2
$28.8M Sell
259,950
-2,296
-0.9% -$270K 0.25% 95
2019
Q1
$34M Sell
262,246
-74,648
-22% -$9.08M 0.3% 84
2018
Q4
$39M Buy
336,894
+74,808
+29% +$8.36M 0.35% 69
2018
Q3
$28.1M Sell
262,086
-101,167
-28% -$10.1M 0.3% 81
2018
Q2
$31M Sell
363,253
-9,821
-3% -$807K 0.27% 81
2018
Q1
$28.9M Sell
373,074
-24,698
-6% -$1.99M 0.22% 109
2017
Q4
$33.6M Buy
397,772
+22,696
+6% +$1.93M 0.24% 98
2017
Q3
$32.1M Sell
375,076
-5,503
-1% -$451K 0.25% 96
2017
Q2
$31.3M Sell
380,579
-38,690
-9% -$3.16M 0.25% 96
2017
Q1
$35.3M Sell
419,269
-24,174
-5% -$1.94M 0.28% 78
2016
Q4
$32.6M Buy
443,443
+68,220
+18% +$5.08M 0.29% 83
2016
Q3
$30.1M Sell
375,223
-83,508
-18% -$6.68M 0.3% 73
2016
Q2
$36.1M Hold
458,731
0.32% 72
2016
Q1
$33M Buy
458,731
+40,688
+10% +$3.08M 0.31% 75
2015
Q4
$35.2M Sell
418,043
-141
-0% -$11.7K 0.34% 66
2015
Q3
$35M Buy
418,184
+4,910
+1% +$415K 0.36% 64
2015
Q2
$34.5M Sell
413,274
-6,687
-2% -$510K 0.33% 70
2015
Q1
$30.5M Sell
419,961
-35,398
-8% -$2.52M 0.28% 87
2014
Q4
$31.4M Sell
455,359
-5,602
-1% -$378K 0.26% 101
2014
Q3
$29.9M Sell
460,961
-33,882
-7% -$2.15M 0.25% 103
2014
Q2
$30.8M Sell
494,843
-36,970
-7% -$2.21M 0.25% 102
2014
Q1
$31.3M Sell
531,813
-135,576
-20% -$7.57M 0.26% 97
2013
Q4
$34M Sell
667,389
-16,838
-2% -$843K 0.27% 96
2013
Q3
$34.4M Sell
684,227
-64,866
-9% -$3.4M 0.29% 86
2013
Q2
$36.8M Buy
+749,093
New +$40.8M 0.3% 80

Other funds holding LLY

British Columbia Investment Management's LLY Position: Q1 2026 in Review

British Columbia Investment Management reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $25.9M and leaving 124,982 shares worth $115M. The position accounts for 0.68% of the portfolio, ranked #24.

British Columbia Investment Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $162M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • British Columbia Investment Management held 124,982 shares of Eli Lilly worth $115M as of Q1 2026.
  • British Columbia Investment Management sold 25,525 Eli Lilly shares in Q1 2026, an estimated $25.9M.
  • Eli Lilly made up 0.68% of British Columbia Investment Management's portfolio in Q1 2026, its #24 holding.
  • British Columbia Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's Eli Lilly position peaked at $162M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.